Canada markets closed

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0300+0.0100 (+50.00%)
At close: 03:53PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 1.17M
Enterprise Value 2.95M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.85
Price/Book (mrq)N/A
Enterprise Value/Revenue 9.91
Enterprise Value/EBITDA -1.26

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 3-95.71%
S&P500 52-Week Change 3-13.51%
52 Week High 30.7900
52 Week Low 30.0150
50-Day Moving Average 30.0825
200-Day Moving Average 30.2939

Share Statistics

Avg Vol (3 month) 339.93k
Avg Vol (10 day) 352.02k
Shares Outstanding 538.91M
Implied Shares Outstanding 6N/A
Float 833M
% Held by Insiders 115.08%
% Held by Institutions 10.00%
Shares Short (Oct 13, 2022) 4187
Short Ratio (Oct 13, 2022) 40.02
Short % of Float (Oct 13, 2022) 4N/A
Short % of Shares Outstanding (Oct 13, 2022) 40.00%
Shares Short (prior month Sept 14, 2022) 4568

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2022
Most Recent Quarter (mrq)Aug 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,395.54%

Management Effectiveness

Return on Assets (ttm)-66.03%
Return on Equity (ttm)-601.85%

Income Statement

Revenue (ttm)297.36k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)11.60%
Gross Profit (ttm)-939.01k
Net Income Avi to Common (ttm)-3.55M
Diluted EPS (ttm)-0.1230
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)145.17k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.93M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.40
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-2.71M
Levered Free Cash Flow (ttm)-1.46M